Enanta Pharmaceuticals Inc (NAS:ENTA)
$ 11.26 0.15 (1.35%) Market Cap: 238.58 Mil Enterprise Value: 55.89 Mil PE Ratio: 0 PB Ratio: 1.60 GF Score: 61/100

Q1 2023 Enanta Pharmaceuticals Inc Earnings Call Transcript

Feb 07, 2023 / 09:30PM GMT
Release Date Price: $54.59 (+3.12%)
Operator

Good afternoon, and welcome to Enanta Pharmaceuticals Fiscal First Quarter Ended December 31, 2022 Financial Results Conference Call. (Operator Instructions)

Please be advised that today's conference is being recorded. I would now like to hand the conference over to Jennifer Viera, Investor Relations. Please go ahead.

Jennifer Viera
Enanta Pharmaceuticals, Inc. - Senior Director of IR & Corporate Communications

Thank you, operator, and thanks to everyone for joining us this afternoon. The news release with our fiscal first quarter 2023 financial results was issued this afternoon and is available on our website. On the call today are Dr. Jay Luly, President and Chief Executive Officer; Paul Mellett, our Chief Financial Officer; and other members of Enanta's senior management team.

Before we begin with our formal remarks, we want to remind you that we will be making forward-looking statements, which may include our plans and expectations with respect to our research and development pipeline and financial projections, all of which involve

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot